×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Intra-Cellular Therapies Inc. (ITCI) NASDAQ

$69.72 2.39 (3.55%)

Market Cap: $6.75B

As of 03/27/24 04:00 PM EDT. Market closed.

(ITCI)

Intra-Cellular Therapies Inc. (ITCI)
NASDAQ

$69.72
2.39 (3.55%)

Market Cap: $6.75B

As of 03/27/24 04:00 PM EDT. Market closed.

Add to Portfolio

intra-cellular therapies is a company based out of 3960 broadway, new york, new york, united ... read more

intra-cellular therapies is a company based out of 3960 broadway, new york, new york, united states. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO Compensation (Base)
$722,800
CEO Compensation (Total)
$4.48M
URL
Address
430 E 29th St, New York, New York, 10016-8367.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Sharon Mates
CEO Compensation (Base)
$722,800
CEO Compensation (Total)
$4.48M
Address
430 E 29th St, New York, New York, 10016-8367.
PRICE CHART FOR INTRA-CELLULAR THERAPIES INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$67.99
Previous Close
$67.33
Days Range
$67.54 - $69.75
52 week range
$45.50 - $76.11
Volume
428,676
Avg. Volume (30 days)
644,540
Market Cap
$6.75B
Dividend Yield
-
P/E
-
Shares Outstanding
96,807,191
Open
$67.99
Previous Close
$67.33
Days Range
$67.54 - $69.75
52 week range
$45.50 - $76.11
Volume
428,676
Avg. Volume (30 days)
644,540
Market Cap
$6.75B
Dividend Yield
-
P/E
-
Shares Outstanding
96,807,191
FINANCIAL STATEMENTS FOR INTRA-CELLULAR THERAPIES INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR INTRA-CELLULAR THERAPIES INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
RIGGS RORY BDirectorMar 20, 2024 Option Exercise$18.5620,000371,20099,235Mar 22, 2024, 04:12 PM
Mates SharonChairman, President & CEOMar 07, 2024 Sale$66.5040,7122,707,2771,059,063Mar 11, 2024, 08:33 PM
Mates SharonChairman, President & CEOMar 11, 2024 Sale$65.2120,5651,341,1231,056,333Mar 11, 2024, 08:33 PM
Hineline Lawrence J.SVP of Finance, CFOMar 10, 2024 Option Exercise$56.734,539257,4974,539Mar 11, 2024, 08:33 PM
Hineline Lawrence J.SVP of Finance, CFOMar 11, 2024 Sale$65.9610,121667,5871,129Mar 11, 2024, 08:33 PM
Hineline Lawrence J.SVP of Finance, CFOMar 07, 2024 Sale$66.6013,132874,5606,618Mar 11, 2024, 08:33 PM
Halstead MichaelEVP and General CounselMar 11, 2024 Sale$65.977,345484,5371,238Mar 11, 2024, 08:32 PM
Halstead MichaelEVP and General CounselMar 07, 2024 Sale$66.1513,132868,698220Mar 11, 2024, 08:32 PM
Neumann MarkEVP, Chief Commercial OfficerMar 11, 2024 Sale$65.617,345481,93132,742Mar 11, 2024, 08:31 PM
Neumann MarkEVP, Chief Commercial OfficerMar 07, 2024 Sale$66.5713,132874,17934,196Mar 11, 2024, 08:31 PM
Durgam Suresh K.EVP, Chief Medical OfficerMar 11, 2024 Sale$65.593,712243,48221,336Mar 11, 2024, 08:31 PM
Durgam Suresh K.EVP, Chief Medical OfficerMar 07, 2024 Sale$66.566,450429,30818,892Mar 11, 2024, 08:31 PM
VAN NOSTRAND ROBERT LDirectorFeb 27, 2024 Option Exercise$18.5620,000371,20029,611Feb 28, 2024, 07:41 PM
VAN NOSTRAND ROBERT LDirectorFeb 27, 2024 Sale$72.9320,0001,458,65019,960Feb 28, 2024, 07:41 PM
Halstead MichaelEVP and General CounselFeb 26, 2024 Sale$69.537,907549,7847,607Feb 27, 2024, 08:00 PM
Hineline Lawrence J.SVP of Finance, CFOFeb 26, 2024 Option Exercise$36.895,882216,9875,882Feb 27, 2024, 08:00 PM
Hineline Lawrence J.SVP of Finance, CFOFeb 26, 2024 Sale$69.4313,337925,9617,155Feb 27, 2024, 08:00 PM
Mates SharonChairman, President & CEOFeb 26, 2024 Sale$69.7922,5901,576,4641,072,299Feb 27, 2024, 07:59 PM
Durgam Suresh K.EVP, Chief Medical OfficerFeb 26, 2024 Sale$70.174,112288,53412,200Feb 27, 2024, 07:58 PM
Neumann MarkEVP, Chief Commercial OfficerFeb 26, 2024 Sale$70.137,907554,49137,407Feb 27, 2024, 07:58 PM
MARCUS JOEL SDirectorFeb 26, 2024 Option Exercise$48.9336,7571,798,67865,990Feb 27, 2024, 07:57 PM
MARCUS JOEL SDirectorFeb 26, 2024 Sale$68.6826,3281,808,25357,619Feb 27, 2024, 07:57 PM
Halstead MichaelEVP and General CounselFeb 02, 2024 Sale$66.4211,860787,719714Feb 05, 2024, 06:13 PM
Mates SharonChairman, President & CEOFeb 02, 2024 Sale$67.0733,8852,272,6931,067,759Feb 05, 2024, 06:10 PM
Neumann MarkEVP, Chief Commercial OfficerFeb 02, 2024 Sale$67.1511,860796,36736,604Feb 05, 2024, 06:07 PM
Hineline Lawrence J.SVP of Finance, CFOFeb 02, 2024 Sale$66.6211,183745,037185Feb 05, 2024, 06:05 PM
Durgam Suresh K.EVP, Chief Medical OfficerFeb 02, 2024 Sale$67.196,167414,3559,540Feb 05, 2024, 06:02 PM
Mates SharonChairman, President & CEOJan 16, 2024 Option Exercise$16.8675,3611,270,5871,125,670Jan 18, 2024, 07:47 PM
Mates SharonChairman, President & CEOJan 18, 2024 Option Exercise$16.8667,9171,145,0811,118,226Jan 18, 2024, 07:47 PM
Mates SharonChairman, President & CEOJan 17, 2024 Option Exercise$16.8648,084810,6961,098,393Jan 18, 2024, 07:47 PM
Mates SharonChairman, President & CEOJan 16, 2024 Sale$67.2575,3615,067,9821,122,170Jan 18, 2024, 07:47 PM
Mates SharonChairman, President & CEOJan 18, 2024 Sale$65.1967,9174,427,8491,050,629Jan 18, 2024, 07:47 PM
Mates SharonChairman, President & CEOJan 17, 2024 Sale$66.2448,0843,185,0621,067,760Jan 18, 2024, 07:47 PM
Halstead MichaelEVP and General CounselJan 11, 2024 Option Exercise$13.6050,000680,05150,000Jan 12, 2024, 06:02 PM
Halstead MichaelEVP and General CounselJan 11, 2024 Sale$66.8350,0003,341,69831,846Jan 12, 2024, 06:02 PM
Durgam Suresh K.EVP, Chief Medical OfficerJan 02, 2024 Option Exercise$19.8762,2821,237,54362,282Jan 04, 2024, 07:54 PM
Durgam Suresh K.EVP, Chief Medical OfficerJan 02, 2024 Sale$70.6062,2824,397,11324,855Jan 04, 2024, 07:54 PM
RIGGS RORY BDirectorDec 31, 2023 Option Exercise$71.6225117,97779,235Jan 03, 2024, 06:46 PM
VAN NOSTRAND ROBERT LDirectorDec 31, 2023 Option Exercise$71.62765,4439,611Jan 03, 2024, 06:43 PM
Durgam Suresh K.EVP, Chief Medical OfficerDec 13, 2023 Sale$65.0021,2621,382,0300Dec 15, 2023, 05:01 PM
Halstead MichaelEVP and General CounselNov 13, 2023 Option Exercise$13.5650,000678,04950,000Nov 14, 2023, 05:33 PM
Halstead MichaelEVP and General CounselNov 13, 2023 Sale$53.9050,0002,694,78341,067Nov 14, 2023, 05:33 PM
Neumann MarkEVP, Chief Commercial OfficerNov 06, 2023 Option Exercise$23.9426,754640,49172,093Nov 08, 2023, 05:31 PM
Neumann MarkEVP, Chief Commercial OfficerNov 06, 2023 Sale$55.6342,3932,358,15245,339Nov 08, 2023, 05:31 PM
VAN NOSTRAND ROBERT LDirectorSep 30, 2023 Option Exercise$52.091055,4699,535Oct 02, 2023, 05:30 PM
RIGGS RORY BDirectorSep 30, 2023 Option Exercise$52.0934517,97178,984Oct 02, 2023, 05:29 PM
Mates SharonChairman, President & CEOSep 19, 2023 Sale$54.1744,4132,405,8521,050,309Sep 19, 2023, 08:40 PM
Mates SharonChairman, President & CEOSep 18, 2023 Sale$53.7655,5872,988,2131,122,841Sep 19, 2023, 08:40 PM
Neumann MarkEVP, Chief Commercial OfficerAug 07, 2023 Option Exercise$18.5955,3001,028,027100,639Aug 09, 2023, 06:05 PM
Neumann MarkEVP, Chief Commercial OfficerAug 07, 2023 Sale$58.7955,3003,251,08745,339Aug 09, 2023, 06:05 PM
Durgam Suresh K.EVP, Chief Medical OfficerJul 17, 2023 Sale$65.001,842119,73021,262Jul 20, 2023, 05:47 PM
VAN NOSTRAND ROBERT LDirectorJun 30, 2023 Option Exercise$63.32855,3829,430Jul 05, 2023, 04:29 PM
Hineline Lawrence J.SVP of Finance CFOJun 14, 2023 Option Exercise$42.3081,8543,462,31781,854Jun 16, 2023, 05:05 PM
Hineline Lawrence J.SVP of Finance CFOJun 14, 2023 Sale$63.9781,8545,236,32947,627Jun 16, 2023, 05:05 PM
VAN NOSTRAND ROBERT LDirectorApr 17, 2023 Option Exercise$13.0510,000130,50019,345Apr 19, 2023, 06:00 PM
VAN NOSTRAND ROBERT LDirectorApr 17, 2023 Sale$63.0010,000630,0009,345Apr 19, 2023, 06:00 PM
RIGGS RORY BDirectorMar 31, 2023 Option Exercise$54.1531316,94978,360Apr 04, 2023, 05:01 PM
Neumann MarkEVP, Chief Commercial OfficerMar 28, 2023 Sale$54.3115,604847,38055,522Mar 30, 2023, 05:08 PM
Durgam Suresh K.EVP, Chief Medical OfficerMar 13, 2023 Sale$45.047,344330,79423,450Mar 13, 2023, 07:36 PM
Neumann MarkEVP, Chief Commercial OfficerMar 13, 2023 Sale$44.983,758169,04261,366Mar 13, 2023, 07:35 PM
Neumann MarkEVP, Chief Commercial OfficerMar 10, 2023 Sale$43.348,550370,55759,157Mar 13, 2023, 07:35 PM
Halstead MichaelEVP and General CounselMar 13, 2023 Sale$44.947,344330,007476Mar 13, 2023, 07:34 PM
Halstead MichaelEVP and General CounselMar 10, 2023 Sale$43.1016,708720,0862,500Mar 13, 2023, 07:34 PM
Hineline Lawrence J.SVP of Finance CFOMar 13, 2023 Sale$44.935,582250,808258Mar 13, 2023, 07:32 PM
Hineline Lawrence J.SVP of Finance CFOMar 10, 2023 Sale$43.0615,663674,4172,700Mar 13, 2023, 07:32 PM
Mates SharonChairman, President & CEOMar 13, 2023 Option Exercise$3.2620,00065,2001,150,309Mar 13, 2023, 07:31 PM
Mates SharonChairman, President & CEOMar 13, 2023 Sale$44.9920,565925,2751,131,721Mar 13, 2023, 07:31 PM
Mates SharonChairman, President & CEOMar 10, 2023 Sale$43.1541,7701,802,5661,137,114Mar 13, 2023, 07:31 PM
Neumann MarkEVP, Chief Commercial OfficerMar 01, 2023 Sale$50.017,241362,12249,199Mar 03, 2023, 07:03 PM
Neumann MarkEVP, Chief Commercial OfficerFeb 24, 2023 Sale$47.124,046190,64856,440Feb 27, 2023, 08:03 PM
Durgam Suresh K.SVP, Chief Medical OfficerFeb 24, 2023 Sale$47.147,906372,68923,104Feb 27, 2023, 08:02 PM
Halstead MichaelEVP and General CounselFeb 24, 2023 Sale$47.037,906371,8190Feb 27, 2023, 08:01 PM
Hineline Lawrence J.SVP of Finance CFOFeb 24, 2023 Sale$47.037,455350,6090Feb 27, 2023, 08:00 PM
Mates SharonChairman, President & CEOFeb 24, 2023 Option Exercise$3.2630,00097,8001,130,309Feb 27, 2023, 07:59 PM
Mates SharonChairman, President & CEOFeb 24, 2023 Sale$47.0322,5901,062,4081,100,309Feb 27, 2023, 07:59 PM
Neumann MarkEVP, Chief Commercial OfficerFeb 21, 2023 Sale$47.013,898183,24653,338Feb 22, 2023, 08:05 PM
Durgam Suresh K.SVP, Chief Medical OfficerFeb 21, 2023 Sale$46.848,354391,30424,785Feb 22, 2023, 08:04 PM
Halstead MichaelEVP and General CounselFeb 21, 2023 Sale$46.8411,139521,6991,843Feb 22, 2023, 08:03 PM
Hineline Lawrence J.SVP of Finance CFOFeb 17, 2023 Option Exercise$12.7353,968687,01353,968Feb 22, 2023, 08:02 PM
Hineline Lawrence J.SVP of Finance CFOFeb 21, 2023 Sale$46.8210,443488,8911,794Feb 22, 2023, 08:02 PM
Hineline Lawrence J.SVP of Finance CFOFeb 17, 2023 Sale$49.8353,9682,689,4641,689Feb 22, 2023, 08:02 PM
Mates SharonChairman, President & CEOFeb 21, 2023 Sale$46.8327,8481,304,0001,105,262Feb 22, 2023, 08:01 PM
VAN NOSTRAND ROBERT LDirectorDec 30, 2022 Option Exercise$52.92975,1339,250Jan 03, 2023, 04:19 PM
RIGGS RORY BDirectorDec 30, 2022 Option Exercise$52.9232116,98778,047Jan 03, 2023, 04:18 PM
MARCUS JOEL SDirectorDec 19, 2022 Sale$50.825,000254,10029,233Dec 21, 2022, 04:06 PM
Mates SharonChairman, President & CEODec 13, 2022 Sale$55.0033,0831,819,5651,100,309Dec 15, 2022, 07:01 PM
Halstead MichaelEVP and General CounselDec 01, 2022 Option Exercise$15.4750,000773,50050,000Dec 02, 2022, 07:14 PM
Halstead MichaelEVP and General CounselDec 01, 2022 Sale$53.7350,0002,686,51422,796Dec 02, 2022, 07:14 PM
MARCUS JOEL SDirectorNov 07, 2022 Sale$52.3010,000523,02339,233Nov 08, 2022, 04:12 PM
VAN NOSTRAND ROBERT LDirectorSep 30, 2022 Option Exercise$46.531105,1189,153Oct 05, 2022, 04:04 PM
RIGGS RORY BDirectorSep 30, 2022 Option Exercise$46.5336516,98377,726Oct 04, 2022, 04:11 PM
Hineline Lawrence J.SVP of Finance CFOSep 21, 2022 Option Exercise$15.4765,1641,008,08765,164Sep 23, 2022, 09:01 PM
Hineline Lawrence J.SVP of Finance CFOSep 21, 2022 Sale$45.6365,1642,973,40633,303Sep 23, 2022, 09:01 PM
VAN NOSTRAND ROBERT LDirectorAug 11, 2022 Option Exercise$12.6530,000379,50039,043Aug 12, 2022, 06:09 PM
VAN NOSTRAND ROBERT LDirectorAug 11, 2022 Sale$57.1330,0001,713,97510,543Aug 12, 2022, 06:09 PM
MARCUS JOEL SDirectorAug 11, 2022 Sale$59.2210,000592,20044,233Aug 12, 2022, 06:05 PM
RIGGS RORY BDirectorJun 30, 2022 Option Exercise$57.0828916,49677,361Jul 05, 2022, 04:06 PM
MARCUS JOEL SDirectorMay 12, 2022 Sale$55.0010,000550,00054,233May 13, 2022, 05:24 PM
Neumann MarkEVP, Chief Commercial OfficerApr 08, 2022 Option Exercise$12.7386,3481,099,210131,687Apr 08, 2022, 06:56 PM
Neumann MarkEVP, Chief Commercial OfficerApr 08, 2022 Sale$64.3786,3485,558,051114,211Apr 08, 2022, 06:56 PM
VAN NOSTRAND ROBERT LDirectorMar 31, 2022 Option Exercise$61.191267,7108,935Apr 04, 2022, 04:11 PM
RIGGS RORY BDirectorMar 31, 2022 Option Exercise$61.1925715,72677,072Apr 04, 2022, 04:08 PM
RIGGS RORY BDirectorMar 18, 2022 Sale$61.1820,6371,262,50515,736Mar 18, 2022, 08:12 PM
RIGGS RORY BDirectorMar 17, 2022 Sale$60.33141,4998,536,646135,549Mar 18, 2022, 08:12 PM
RIGGS RORY BDirectorMar 16, 2022 Sale$59.2764,5343,824,827205,984Mar 18, 2022, 08:12 PM
Mates SharonChairman, President & CEOMar 09, 2022 Option Exercise$2.8438,925110,5471,133,392Mar 10, 2022, 04:13 PM
MARCUS JOEL SDirectorMar 08, 2022 Sale$52.6815,000790,15038,980Mar 09, 2022, 09:49 PM
MARCUS JOEL SDirectorMar 07, 2022 Sale$54.525,000272,60043,980Mar 09, 2022, 09:49 PM
Durgam Suresh K.Chief Medical OfficerMar 02, 2022 Sale$56.984,177238,00526,964Mar 04, 2022, 06:05 PM
Durgam Suresh K.Chief Medical OfficerMar 04, 2022 Sale$55.523,860214,30723,104Mar 04, 2022, 06:05 PM
Durgam Suresh K.Chief Medical OfficerFeb 24, 2022 Sale$52.274,046211,46833,984Feb 25, 2022, 07:09 PM
Neumann MarkEVP, Chief Commercial OfficerFeb 24, 2022 Sale$52.217,906412,81050,585Feb 25, 2022, 07:08 PM
Halstead MichaelEVP and General CounselFeb 24, 2022 Sale$51.987,906410,9334,188Feb 25, 2022, 07:06 PM
Hineline Lawrence J.SVP of Finance CFOFeb 24, 2022 Sale$51.977,454387,3494,083Feb 25, 2022, 07:04 PM
Mates SharonChairman, President & CEOFeb 24, 2022 Sale$51.9822,5891,174,0741,105,807Feb 25, 2022, 07:01 PM
Durgam Suresh K.Chief Medical OfficerFeb 22, 2022 Sale$55.294,177230,95828,638Feb 23, 2022, 07:08 PM
Neumann MarkEVP, Chief Commercial OfficerFeb 22, 2022 Sale$55.2911,139615,82749,946Feb 23, 2022, 07:07 PM
Halstead MichaelEVP and General CounselFeb 22, 2022 Sale$55.4011,139617,1004,550Feb 23, 2022, 07:05 PM
Hineline Lawrence J.SVP of Finance CFOFeb 22, 2022 Sale$55.4010,443578,5064,627Feb 23, 2022, 07:02 PM
Mates SharonChairman, President & CEOFeb 22, 2022 Sale$55.3927,8471,542,4131,107,134Feb 23, 2022, 07:00 PM
Durgam Suresh K.Chief Medical OfficerJan 18, 2022 Sale$42.036,223261,55323,104Jan 20, 2022, 04:07 PM
Durgam Suresh K.Chief Medical OfficerJan 10, 2022 Sale$40.766,870280,02034,677Jan 11, 2022, 08:08 PM
Neumann MarkEVP, Chief Commercial OfficerJan 10, 2022 Sale$40.7820,948854,25563,526Jan 11, 2022, 08:06 PM
Halstead MichaelEVP and General CounselJan 10, 2022 Sale$40.7719,639800,77417,135Jan 11, 2022, 08:04 PM
Hineline Lawrence J.SVP of Finance CFOJan 10, 2022 Sale$40.7619,639800,42016,534Jan 11, 2022, 08:02 PM
Mates SharonChairman, President & CEOJan 10, 2022 Sale$40.7841,8961,708,4291,130,559Jan 11, 2022, 08:00 PM
VAN NOSTRAND ROBERT LDirectorDec 31, 2021 Option Exercise$52.341487,7468,809Jan 04, 2022, 09:52 PM
RIGGS RORY BDirectorDec 31, 2021 Option Exercise$52.3430015,70276,815Jan 04, 2022, 09:50 PM
Halstead MichaelEVP and General CounselDec 21, 2021 Option Exercise$16.38176,8632,897,494176,863Dec 23, 2021, 07:02 PM
Halstead MichaelEVP and General CounselDec 21, 2021 Sale$47.56176,8638,412,278154,243Dec 23, 2021, 07:02 PM
Hineline Lawrence J.SVP of Finance CFODec 21, 2021 Option Exercise$16.81175,0002,941,951175,000Dec 23, 2021, 07:00 PM
Hineline Lawrence J.SVP of Finance CFODec 21, 2021 Sale$47.59175,0008,328,664149,538Dec 23, 2021, 07:00 PM
Neumann MarkEVP, Chief Commercial OfficerOct 18, 2021 Sale$40.8613,448549,55152,085Oct 19, 2021, 04:26 PM
Mates SharonChairman, President & CEOOct 15, 2021 Option Exercise$2.841,0753,0531,102,659Oct 18, 2021, 06:00 PM
Mates SharonChairman, President & CEOOct 15, 2021 Sale$40.0040,3921,615,6801,101,584Oct 18, 2021, 06:00 PM
Mates SharonChairman, President & CEOOct 14, 2021 Sale$40.001,41656,6401,141,976Oct 18, 2021, 06:00 PM
Mates SharonChairman, President & CEOOct 18, 2021 Sale$40.008,192327,6801,094,467Oct 18, 2021, 06:00 PM
LERNER RICHARD ADirectorSep 30, 2021 Option Exercise$37.2840214,98796,663Oct 04, 2021, 05:43 PM
RIGGS RORY BDirectorSep 30, 2021 Option Exercise$37.2842215,73276,515Oct 04, 2021, 04:24 PM
VAN NOSTRAND ROBERT LDirectorSep 30, 2021 Option Exercise$37.282158,0158,661Oct 04, 2021, 04:23 PM
Mates SharonChairman, President & CEOAug 23, 2021 Option Exercise$2.8410,00028,4001,143,392Aug 24, 2021, 04:06 PM
VAN NOSTRAND ROBERT LDirectorJun 30, 2021 Option Exercise$40.821737,0628,446Jul 02, 2021, 04:55 PM
RIGGS RORY BDirectorJun 30, 2021 Option Exercise$40.8238515,71676,093Jul 02, 2021, 04:52 PM
LERNER RICHARD ADirectorJun 30, 2021 Option Exercise$40.8236714,98196,261Jul 02, 2021, 04:47 PM
Alafi Christopher DDirectorMay 24, 2021 Sale$40.4726,5751,075,490142,325May 25, 2021, 06:02 PM
Alafi Christopher DDirectorMay 21, 2021 Sale$40.001,10044,000168,900May 25, 2021, 06:02 PM
LERNER RICHARD ADirectorMar 31, 2021 Option Exercise$33.9344214,99795,894Apr 02, 2021, 05:31 PM
MARCUS JOEL SDirectorMar 02, 2021 Option Exercise$26.5820,000531,60087,519Mar 04, 2021, 05:43 PM
MARCUS JOEL SDirectorMar 02, 2021 Sale$34.9315,250532,68372,269Mar 04, 2021, 05:43 PM
Durgam Suresh K.Chief Medical OfficerFeb 19, 2021 Sale$39.252,734107,31023,304Feb 22, 2021, 08:09 PM
Neumann MarkEVP, Chief Commercial OfficerFeb 19, 2021 Sale$39.225,184203,30845,939Feb 22, 2021, 08:07 PM
Hineline Lawrence J.SVP of Finance CFOFeb 19, 2021 Sale$39.2310,442409,6251,200Feb 22, 2021, 08:05 PM
Halstead MichaelEVP and General CounselFeb 19, 2021 Sale$39.2411,139437,1331,100Feb 22, 2021, 08:03 PM
Mates SharonChairman, President & CEOFeb 19, 2021 Sale$39.2327,8471,092,4361,136,492Feb 22, 2021, 08:01 PM
Durgam Suresh K.Chief Medical OfficerJan 11, 2021 Sale$32.124,367140,25917,584Jan 12, 2021, 07:07 PM
Neumann MarkEVP, Chief Commercial OfficerJan 11, 2021 Sale$32.029,684310,08239,384Jan 12, 2021, 07:06 PM
Hineline Lawrence J.SVP of Finance CFOJan 11, 2021 Sale$32.0219,638628,7692,376Jan 12, 2021, 07:05 PM
Halstead MichaelEVP and General CounselJan 11, 2021 Sale$32.0319,638628,9781,936Jan 12, 2021, 07:03 PM
Mates SharonChairman, President & CEOJan 11, 2021 Sale$32.0141,8961,341,2601,137,977Jan 12, 2021, 07:01 PM
Hineline Lawrence J.SVP of Finance CFOJan 04, 2021 Sale$31.3115,810495,0083,450Jan 05, 2021, 06:13 PM
Halstead MichaelEVP and General CounselJan 04, 2021 Sale$31.3016,160505,8343,174Jan 05, 2021, 06:11 PM
Mates SharonChairman, President & CEOJan 04, 2021 Sale$31.3048,3411,513,2711,153,820Jan 05, 2021, 06:09 PM
LERNER RICHARD ADirectorDec 31, 2020 Option Exercise$31.8047114,97895,452Jan 05, 2021, 06:07 PM
VAN NOSTRAND ROBERT LDirectorDec 31, 2020 Option Exercise$31.802227,0608,065Jan 05, 2021, 06:05 PM
RIGGS RORY BDirectorDec 31, 2020 Option Exercise$31.8049515,74161,477Jan 05, 2021, 06:03 PM
Alafi Christopher DDirectorDec 31, 2020 Option Exercise$31.8049515,741346,331Jan 05, 2021, 06:01 PM
Mates SharonChairman, President & CEODec 18, 2020 Option Exercise$2.7434,00093,1601,147,392Dec 21, 2020, 04:03 PM
Halstead MichaelEVP and General CounselNov 17, 2020 Option Exercise$13.8675,0001,039,50079,425Nov 19, 2020, 08:05 PM
Halstead MichaelEVP and General CounselNov 17, 2020 Sale$27.6279,4252,193,4463,761Nov 19, 2020, 08:05 PM
Hineline Lawrence J.SVP of Finance CFONov 11, 2020 Option Exercise$3.0520,00061,00028,034Nov 13, 2020, 05:51 PM
Hineline Lawrence J.SVP of Finance CFONov 11, 2020 Sale$25.4128,034712,3440Nov 13, 2020, 05:51 PM
Mates SharonChairman, President & CEONov 10, 2020 Sale$26.3450,0001,317,1011,132,523Nov 12, 2020, 05:51 PM
Mates SharonChairman, President & CEONov 04, 2020 Sale$25.0050,0001,250,0001,163,392Nov 06, 2020, 06:00 PM
Neumann MarkEVP, Chief Commercial OfficerOct 16, 2020 Sale$26.806,792182,02628,120Oct 16, 2020, 04:04 PM
VAN NOSTRAND ROBERT LDirectorSep 30, 2020 Option Exercise$25.662767,0827,843Oct 02, 2020, 04:24 PM
RIGGS RORY BDirectorSep 30, 2020 Option Exercise$25.6661315,73060,982Oct 02, 2020, 04:22 PM
LERNER RICHARD ADirectorSep 30, 2020 Option Exercise$25.6658414,98594,981Oct 02, 2020, 04:17 PM
Alafi Christopher DDirectorSep 30, 2020 Option Exercise$25.6661315,730345,836Oct 02, 2020, 04:13 PM
Alafi Christopher DDirectorSep 14, 2020 Buy$29.6049,5001,465,2004,743,770Sep 14, 2020, 05:03 PM
Hineline Lawrence J.SVP of Finance CFOSep 09, 2020 Option Exercise$12.7326,983343,49450,017Sep 11, 2020, 07:08 PM
Hineline Lawrence J.SVP of Finance CFOSep 09, 2020 Sale$31.1441,9831,307,3518,034Sep 11, 2020, 07:08 PM
Alafi Christopher DDirectorSep 11, 2020 Buy$28.0821,000589,6804,694,270Sep 11, 2020, 04:15 PM
VAN NOSTRAND ROBERT LDirectorJun 30, 2020 Option Exercise$25.672757,0597,567Jul 02, 2020, 07:12 PM
LERNER RICHARD ADirectorJun 30, 2020 Option Exercise$25.6758414,99194,397Jul 02, 2020, 07:05 PM
RIGGS RORY BDirectorJun 30, 2020 Option Exercise$25.6761315,73660,369Jul 02, 2020, 07:02 PM
Alafi Christopher DDirectorJun 30, 2020 Option Exercise$25.6761315,736345,223Jul 02, 2020, 06:58 PM
MARCUS JOEL SDirectorMay 14, 2020 Sale$20.049,602192,42439,140May 15, 2020, 05:37 PM
MARCUS JOEL SDirectorMay 11, 2020 Sale$19.9550,000997,50048,742May 13, 2020, 07:48 PM
MARCUS JOEL SDirectorMay 13, 2020 Sale$20.637,297150,53714,374May 13, 2020, 07:48 PM
LERNER RICHARD ADirectorMay 11, 2020 Option Exercise$2.7425,00068,50097,313May 13, 2020, 05:20 PM
LERNER RICHARD ADirectorMay 11, 2020 Sale$20.503,50071,75093,813May 13, 2020, 05:20 PM
Alafi Christopher DDirectorMar 31, 2020 Option Exercise$15.371,02415,739344,610Apr 02, 2020, 06:05 PM
LERNER RICHARD ADirectorMar 31, 2020 Option Exercise$15.3797514,98672,313Apr 02, 2020, 06:01 PM
VAN NOSTRAND ROBERT LDirectorMar 31, 2020 Option Exercise$15.374607,0707,292Apr 02, 2020, 05:55 PM
RIGGS RORY BDirectorMar 31, 2020 Option Exercise$15.371,02415,73945,751Apr 02, 2020, 05:50 PM
Halstead MichaelEVP and General CounselJan 24, 2020 Option Exercise$23.613,80989,9304,425Jan 28, 2020, 09:31 PM
Hineline Lawrence J.SVP of Finance CFOJan 24, 2020 Option Exercise$23.613,80989,93023,034Jan 28, 2020, 09:30 PM
Mates SharonChairman, President & CEOJan 24, 2020 Option Exercise$23.619,323220,1161,213,392Jan 28, 2020, 09:28 PM
LERNER RICHARD ADirectorDec 31, 2019 Option Exercise$34.3140013,72471,338Jan 16, 2020, 06:13 PM
Satlin AndrewEVP and Chief Medical OfficerJan 09, 2020 Sale$26.1611,573302,75011,338Jan 10, 2020, 09:14 PM
Neumann MarkEVP, Chief Commercial OfficerJan 08, 2020 Option Exercise$26.346,157162,17521,464Jan 10, 2020, 09:11 PM
Mates SharonChairman, President & CEOJan 09, 2020 Sale$26.1641,8951,095,9731,204,707Jan 10, 2020, 09:09 PM
Halstead MichaelEVP and General CounselJan 09, 2020 Sale$26.1619,638513,730191Jan 10, 2020, 09:06 PM
Hineline Lawrence J.SVP of Finance CFOJan 09, 2020 Sale$26.1619,638513,73018,800Jan 10, 2020, 09:03 PM
Mates SharonChairman, President & CEOJan 08, 2020 Option Exercise$2.7460,000164,4001,246,602Jan 08, 2020, 09:11 PM
Mates SharonChairman, President & CEOJan 06, 2020 Sale$30.2845,5981,380,8801,182,366Jan 08, 2020, 09:11 PM
Halstead MichaelEVP and General CounselJan 06, 2020 Sale$30.3421,458651,00717,704Jan 08, 2020, 09:02 PM
Hineline Lawrence J.SVP of Finance CFOJan 06, 2020 Sale$30.2921,458650,00336,391Jan 08, 2020, 09:00 PM
Halstead MichaelEVP and General CounselJan 02, 2020 Sale$32.437,807253,2146,375Jan 03, 2020, 09:17 PM
Hineline Lawrence J.SVP of Finance CFOJan 02, 2020 Sale$32.437,807253,16525,807Jan 03, 2020, 09:16 PM
Mates SharonChairman, President & CEODec 31, 2019 Option Exercise$2.746,00016,4401,162,185Jan 03, 2020, 09:14 PM
Mates SharonChairman, President & CEOJan 02, 2020 Sale$32.4517,478567,2301,158,485Jan 03, 2020, 09:14 PM
VAN NOSTRAND ROBERT LDirectorDec 31, 2019 Option Exercise$34.311705,8336,832Jan 03, 2020, 09:13 PM
RIGGS RORY BDirectorDec 31, 2019 Option Exercise$34.3142214,47944,727Jan 03, 2020, 09:12 PM
Alafi Christopher DDirectorDec 31, 2019 Option Exercise$34.3142214,479343,586Jan 03, 2020, 09:11 PM
Hineline Lawrence J.SVP of Finance CFODec 23, 2019 Option Exercise$2.749,60026,30434,832Dec 26, 2019, 04:06 PM
Hineline Lawrence J.SVP of Finance CFODec 23, 2019 Sale$25.5015,032383,31625,232Dec 26, 2019, 04:06 PM
Neumann MarkEVP, Chief Commercial OfficerOct 16, 2019 Sale$8.256,77455,8866,674Oct 17, 2019, 04:50 PM
RIGGS RORY BDirectorSep 30, 2019 Option Exercise$7.471,94114,49944,305Oct 02, 2019, 05:37 PM
LERNER RICHARD ADirectorSep 30, 2019 Option Exercise$7.471,84013,74570,938Oct 02, 2019, 05:35 PM
VAN NOSTRAND ROBERT LDirectorSep 30, 2019 Option Exercise$7.477805,8276,662Oct 02, 2019, 05:32 PM
Alafi Christopher DDirectorSep 30, 2019 Option Exercise$7.471,94114,499343,164Oct 02, 2019, 05:29 PM
Alafi Christopher DDirectorSep 10, 2019 Buy$10.26485,0004,974,6784,673,270Sep 11, 2019, 04:30 PM
Alafi Christopher DDirectorAug 30, 2019 Buy$8.52125,0001,065,2124,188,270Sep 04, 2019, 06:24 PM
VAN NOSTRAND ROBERT LDirectorJun 28, 2019 Option Exercise$12.984495,8285,882Jul 02, 2019, 05:17 PM
LERNER RICHARD ADirectorJun 28, 2019 Option Exercise$12.981,05913,74669,098Jul 02, 2019, 05:12 PM
RIGGS RORY BDirectorJun 28, 2019 Option Exercise$12.981,11714,49942,364Jul 02, 2019, 05:03 PM
Alafi Christopher DDirectorJun 28, 2019 Option Exercise$12.981,11714,499341,223Jul 02, 2019, 12:00 AM
Alafi Christopher DDirectorNov 22, 2017 Buy$15.5510,000155,5003,963,270Jun 19, 2019, 05:48 PM
Alafi Christopher DDirectorJun 12, 2019 Buy$11.73170,0001,993,793170,000Jun 14, 2019, 05:23 PM
MARCUS JOEL SDirectorMay 29, 2019 Option Exercise$12.4520,000249,00041,671May 31, 2019, 04:35 PM
Alafi Christopher DDirectorMay 14, 2019 Buy$12.56100,0001,256,3504,053,270May 15, 2019, 06:03 PM
Alafi Christopher DDirectorMar 31, 2019 Option Exercise$12.181,19014,494750,106Apr 02, 2019, 07:03 PM
VAN NOSTRAND ROBERT LDirectorMar 31, 2019 Option Exercise$12.184785,8225,433Apr 02, 2019, 06:59 PM
RIGGS RORY BDirectorMar 31, 2019 Option Exercise$12.181,19014,49441,247Apr 02, 2019, 06:56 PM
LERNER RICHARD ADirectorMar 31, 2019 Option Exercise$12.181,12813,73968,039Apr 02, 2019, 06:52 PM
Hineline Lawrence J.SVP of Finance CFOFeb 27, 2019 Option Exercise$2.7410,40028,49626,232Mar 01, 2019, 07:41 PM
Hineline Lawrence J.SVP of Finance CFOFeb 27, 2019 Sale$15.001,00015,00025,232Mar 01, 2019, 07:41 PM
Mates SharonChairman, President & CEOJan 07, 2019 Sale$12.436,60482,0881,138,707Jan 08, 2019, 09:28 PM
Mates SharonChairman, President & CEOJan 04, 2019 Sale$11.4545,598522,2221,152,850Jan 08, 2019, 09:28 PM
Halstead MichaelEVP and General CounselJan 07, 2019 Sale$12.423,10838,601191Jan 08, 2019, 09:24 PM
Halstead MichaelEVP and General CounselJan 04, 2019 Sale$11.4621,458245,8178,697Jan 08, 2019, 09:24 PM
Hineline Lawrence J.SVP of Finance CFOJan 07, 2019 Sale$12.423,10838,60117,032Jan 08, 2019, 09:21 PM
Hineline Lawrence J.SVP of Finance CFOJan 04, 2019 Sale$11.4521,458245,78221,882Jan 08, 2019, 09:21 PM
Vanover Kimberly E.SVP, Early Stage Clinical Dev.Jan 04, 2019 Sale$11.479,564109,70429,844Jan 08, 2019, 09:19 PM
Vanover Kimberly E.SVP, Early Stage Clinical Dev.Jan 07, 2019 Sale$12.295927,27627,068Jan 08, 2019, 09:19 PM
Davis Robert ESVP, Chief Scientific OfficerJan 04, 2019 Sale$11.469,564109,63046,691Jan 08, 2019, 09:16 PM
Mates SharonChairman, President & CEOJan 02, 2019 Sale$11.0917,478193,8311,138,707Jan 03, 2019, 09:02 PM
Halstead MichaelEVP and General CounselJan 02, 2019 Sale$11.097,80786,580191Jan 03, 2019, 08:58 PM
Vanover Kimberly E.SVP, Early Stage Clinical Dev.Jan 02, 2019 Sale$11.104,83453,65716,861Jan 03, 2019, 08:46 PM
Davis Robert ESVP, Chief Scientific OfficerJan 02, 2019 Sale$11.114,83453,70634,744Jan 03, 2019, 08:42 PM
Hineline Lawrence J.SVP of Finance CFOJan 02, 2019 Sale$11.097,80786,58017,032Jan 03, 2019, 08:23 PM
VAN NOSTRAND ROBERT LDirectorDec 31, 2018 Option Exercise$11.395125,8324,955Jan 03, 2019, 08:19 PM
RIGGS RORY BDirectorDec 31, 2018 Option Exercise$11.391,27314,49940,057Jan 03, 2019, 08:15 PM
LERNER RICHARD ADirectorDec 31, 2018 Option Exercise$11.391,20713,74811,430Jan 03, 2019, 08:11 PM
Alafi Christopher DDirectorDec 31, 2018 Option Exercise$11.391,27314,499748,916Jan 03, 2019, 08:05 PM
Mates SharonChairman, President & CEODec 10, 2018 Option Exercise$1.5050,00075,0001,138,707Dec 11, 2018, 05:55 PM
Davis Robert ESVP, Chief Scientific OfficerDec 06, 2018 Sale$13.5389912,16330,256Dec 07, 2018, 04:44 PM
MARCUS JOEL SDirectorNov 12, 2018 Sale$17.947,000125,58078,742Nov 13, 2018, 05:34 PM
MARCUS JOEL SDirectorNov 09, 2018 Sale$18.2425,000456,00085,742Nov 13, 2018, 05:34 PM
LERNER RICHARD ADirectorOct 22, 2018 Option Exercise$1.5012,50018,75066,911Oct 24, 2018, 04:33 PM
LERNER RICHARD ADirectorSep 30, 2018 Option Exercise$21.7063313,73654,411Oct 02, 2018, 08:11 PM
RIGGS RORY BDirectorSep 30, 2018 Option Exercise$21.7066814,49638,784Oct 02, 2018, 08:08 PM
VAN NOSTRAND ROBERT LDirectorSep 30, 2018 Option Exercise$21.702685,8164,443Oct 02, 2018, 08:06 PM
Alafi Christopher DDirectorSep 30, 2018 Option Exercise$21.7066814,496747,643Oct 02, 2018, 08:01 PM
LERNER RICHARD ADirectorJun 29, 2018 Option Exercise$17.6777813,74753,778Jul 03, 2018, 04:27 PM
Alafi Christopher DDirectorJun 29, 2018 Option Exercise$17.6782014,489746,975Jul 03, 2018, 12:00 AM
VAN NOSTRAND ROBERT LDirectorJun 29, 2018 Option Exercise$17.672824,9834,175Jul 03, 2018, 12:00 AM
RIGGS RORY BDirectorJun 29, 2018 Option Exercise$17.6782014,48938,116Jul 03, 2018, 12:00 AM
VAN NOSTRAND ROBERT LDirectorMar 30, 2018 Option Exercise$21.052374,9893,893Apr 03, 2018, 04:19 PM
RIGGS RORY BDirectorMar 30, 2018 Option Exercise$21.0568814,48237,296Apr 03, 2018, 12:00 AM
LERNER RICHARD ADirectorMar 30, 2018 Option Exercise$21.0565313,74610,223Apr 03, 2018, 12:00 AM
Alafi Christopher DDirectorMar 30, 2018 Option Exercise$21.0568814,482746,155Apr 03, 2018, 12:00 AM
Hineline Lawrence J.VP of Finance CFOFeb 16, 2018 Sale$20.0116,319326,54317,032Feb 20, 2018, 04:38 PM
Hineline Lawrence J.VP of Finance CFOFeb 15, 2018 Sale$20.0333,381668,62133,351Feb 20, 2018, 04:38 PM
Halstead MichaelSVP and General CounselJan 22, 2018 Sale$18.0325,500459,765191Jan 24, 2018, 07:11 PM
Vanover Kimberly E.SVP, Clinical DevelopmentJan 08, 2018 Sale$17.4677213,47912,373Jan 10, 2018, 09:05 PM
Mates SharonChairman, President & CEOJan 08, 2018 Sale$17.486,604115,4381,088,707Jan 10, 2018, 09:01 PM
Mates SharonChairman, President & CEOJan 05, 2018 Sale$17.0811,257192,2701,095,311Jan 05, 2018, 08:19 PM
Vanover Kimberly E.SVP, Clinical DevelopmentJan 05, 2018 Sale$17.371,18520,58313,145Jan 05, 2018, 08:14 PM
Davis Robert ESVP, Chief Scientific OfficerJan 04, 2018 Sale$15.601,11517,39429,397Jan 05, 2018, 08:09 PM
Hineline Lawrence J.VP of Finance CFOJan 04, 2018 Sale$15.673,19250,01968,602Jan 05, 2018, 08:06 PM
Hineline Lawrence J.VP of Finance CFOJan 05, 2018 Sale$17.491,87032,70666,732Jan 05, 2018, 08:06 PM
Halstead MichaelSVP and General CounselJan 05, 2018 Sale$17.491,56027,28425,691Jan 05, 2018, 08:03 PM
Halstead MichaelSVP and General CounselJan 04, 2018 Sale$15.752,66041,89527,251Jan 05, 2018, 08:03 PM
VAN NOSTRAND ROBERT LDirectorDec 29, 2017 Option Exercise$14.483454,9963,656Jan 03, 2018, 06:10 PM
RIGGS RORY BDirectorDec 29, 2017 Option Exercise$14.481,00114,49436,608Jan 03, 2018, 06:05 PM
LERNER RICHARD ADirectorDec 29, 2017 Option Exercise$14.4894913,7429,570Jan 03, 2018, 06:01 PM
Alafi Christopher DDirectorDec 29, 2017 Option Exercise$14.481,00114,494745,467Jan 03, 2018, 05:59 PM
VAN NOSTRAND ROBERT LDirectorDec 29, 2017 Buy$14.483454,9963,656Jan 03, 2018, 04:31 PM
LERNER RICHARD ADirectorDec 29, 2017 Buy$14.4894913,7429,570Jan 03, 2018, 04:29 PM
RIGGS RORY BDirectorDec 29, 2017 Buy$14.481,00114,49436,608Jan 03, 2018, 12:00 AM
Alafi Christopher DDirectorDec 29, 2017 Buy$14.481,00114,494745,467Jan 03, 2018, 12:00 AM
LERNER RICHARD ADirectorDec 11, 2017 Option Exercise$1.5012,50018,75060,000Dec 13, 2017, 04:52 PM
LERNER RICHARD ADirectorDec 11, 2017 Sale$15.097,000105,63053,000Dec 13, 2017, 04:52 PM
Davis Robert ESVP, Chief Scientific OfficerDec 05, 2017 Sale$15.006509,75027,864Dec 06, 2017, 06:33 PM
Alafi Christopher DDirectorNov 22, 2017 Buy$15.5510,000155,500744,466Nov 27, 2017, 04:31 PM
Mates SharonChairman, President & CEOOct 30, 2017 Option Exercise$1.5018,75028,1251,107,457Nov 01, 2017, 08:04 PM
Mates SharonChairman, President & CEOOct 30, 2017 Sale$15.7518,750295,3131,088,707Nov 01, 2017, 08:04 PM
ALAFI MOSHE10% OwnerOct 02, 2017 Buy$15.50258,0654,000,0083,953,270Oct 03, 2017, 06:11 PM
Alafi Christopher DDirectorOct 02, 2017 Buy$15.50258,0654,000,0083,953,270Oct 03, 2017, 06:10 PM
ALAFI CAPITAL CO LLC10% OwnerOct 02, 2017 Buy$15.50258,0654,000,0083,953,270Oct 03, 2017, 06:08 PM
MARCUS JOEL SDirectorJan 26, 2017 Option Exercise$2.6095,000247,450116,671Jan 30, 2017, 06:13 PM
Vanover Kimberly E.SVP, Clinical DevelopmentJan 05, 2017 Sale$16.5980013,27210,128Jan 09, 2017, 05:34 PM
Mates SharonChairman, President & CEOJan 05, 2017 Sale$16.554,08167,5411,088,707Jan 09, 2017, 05:31 PM
Hineline Lawrence J.VP of Finance CFOJan 05, 2017 Sale$16.581,91831,80063,389Jan 09, 2017, 05:29 PM
Halstead MichaelSVP and General CounselJan 05, 2017 Sale$16.551,60126,49721,506Jan 09, 2017, 05:27 PM
Vanover Kimberly E.SVP, Clinical DevelopmentDec 15, 2016 Option Exercise$1.4618,75027,42512,500Dec 19, 2016, 05:50 PM
Vanover Kimberly E.SVP, Clinical DevelopmentDec 15, 2016 Sale$15.239,375142,7739,375Dec 19, 2016, 05:50 PM
ALAFI MOSHE10% OwnerDec 07, 2016 Buy$16.1420,826336,0383,695,205Dec 07, 2016, 04:35 PM
ALAFI MOSHE10% OwnerDec 06, 2016 Buy$16.3344,174721,4453,674,379Dec 07, 2016, 04:35 PM
Alafi Christopher DDirectorDec 07, 2016 Buy$16.1420,826336,0383,695,205Dec 07, 2016, 04:32 PM
Alafi Christopher DDirectorDec 06, 2016 Buy$16.3344,174721,4453,674,379Dec 07, 2016, 04:32 PM
ALAFI CAPITAL CO LLC10% OwnerDec 07, 2016 Buy$16.1420,826336,0383,695,205Dec 07, 2016, 04:21 PM
ALAFI CAPITAL CO LLC10% OwnerDec 06, 2016 Buy$16.3344,174721,4453,674,379Dec 07, 2016, 04:21 PM
ALAFI MOSHE10% OwnerNov 14, 2016 Buy$14.5034,000492,9693,630,205Nov 17, 2016, 04:35 PM
ALAFI CAPITAL CO LLC10% OwnerNov 14, 2016 Buy$14.5034,000492,9693,630,205Nov 17, 2016, 04:34 PM
Alafi Christopher DDirectorNov 14, 2016 Buy$14.5034,000492,9693,630,205Nov 17, 2016, 04:32 PM
RIGGS RORY BDirectorFeb 05, 2014 Buy$17.5014,285249,98826,091Apr 20, 2016, 04:30 PM
RIGGS RORY BDirectorFeb 05, 2014 Buy$17.5014,286250,005226,670Apr 20, 2016, 04:30 PM
Alafi Christopher DDirectorFeb 29, 2016 Buy$29.70100,0002,970,300728,828Feb 29, 2016, 05:32 PM
LERNER RICHARD ADirectorFeb 18, 2016 Option Exercise$1.3610,00013,60047,500Feb 19, 2016, 04:25 PM
VAN NOSTRAND ROBERT LDirectorDec 31, 2015 Option Exercise$53.79693,7121,365Jan 05, 2016, 07:09 PM
RIGGS RORY BDirectorDec 31, 2015 Option Exercise$53.7919710,59715,679Jan 05, 2016, 05:13 PM
MARCUS JOEL SDirectorDec 31, 2015 Option Exercise$53.7919910,70418,921Jan 05, 2016, 05:11 PM
Alafi Christopher DDirectorDec 31, 2015 Option Exercise$53.7919510,489628,828Jan 05, 2016, 05:00 PM
LERNER RICHARD ADirectorDec 31, 2015 Option Exercise$53.7918810,1133,266Jan 05, 2016, 04:59 PM
Mates SharonChairman, President & CEODec 11, 2015 Option Exercise$1.1268,75077,1251,137,685Dec 15, 2015, 08:27 PM
Mates SharonChairman, President & CEODec 11, 2015 Sale$53.8751,5002,774,4411,107,639Dec 15, 2015, 08:27 PM
Hineline Lawrence J.VP of Finance CFODec 15, 2015 Option Exercise$1.4535,00050,75074,700Dec 15, 2015, 08:25 PM
Hineline Lawrence J.VP of Finance CFODec 14, 2015 Option Exercise$0.607,5004,50072,200Dec 15, 2015, 08:25 PM
Hineline Lawrence J.VP of Finance CFONov 24, 2015 Option Exercise$0.605,0003,00064,700Dec 15, 2015, 08:25 PM
Hineline Lawrence J.VP of Finance CFODec 15, 2015 Sale$51.9722,5001,169,22663,464Dec 15, 2015, 08:25 PM
Hineline Lawrence J.VP of Finance CFODec 14, 2015 Sale$50.9422,5001,146,14062,307Dec 15, 2015, 08:25 PM
MARCUS JOEL SDirectorDec 08, 2015 Sale$54.8022,7001,243,9601,191,156Dec 08, 2015, 05:30 PM
MARCUS JOEL SDirectorDec 07, 2015 Sale$53.1740,0002,126,6281,238,781Dec 08, 2015, 05:30 PM
MARCUS JOEL SDirectorDec 04, 2015 Sale$55.9630,0001,678,8001,253,856Dec 08, 2015, 05:30 PM
Hineline Lawrence J.VP of Finance CFONov 24, 2015 Sale$55.005,000275,00059,700Nov 27, 2015, 08:29 AM
Fienberg Allen A.VP of Business DevelopmentSep 09, 2015 Option Exercise$1.3612,50017,000295,000Sep 11, 2015, 04:53 PM
Fienberg Allen A.VP of Business DevelopmentAug 21, 2015 Sale$30.302006,060197,823Sep 11, 2015, 04:53 PM
Fienberg Allen A.VP of Business DevelopmentAug 19, 2015 Sale$30.3010,000303,000198,023Sep 11, 2015, 04:53 PM
Wennogle Lawrence P.Vice President, Drug DiscoveryJun 08, 2015 Sale$26.8425,000671,000126,500Jun 09, 2015, 05:04 PM
Wennogle Lawrence P.Vice President, Drug DiscoveryMay 19, 2015 Option Exercise$1.2347,50058,250151,500May 20, 2015, 05:19 PM
Fienberg Allen A.VP of Business DevelopmentMar 31, 2015 Option Exercise$0.6012,5007,500282,500Apr 02, 2015, 04:59 PM
MARCUS JOEL SDirectorMar 31, 2015 Option Exercise$1.2315,00018,40018,118Apr 02, 2015, 04:58 PM
Alafi Christopher DDirectorMar 11, 2015 Buy$24.00625,00015,000,000627,604Mar 12, 2015, 06:24 PM
Fienberg Allen A.VP of Business DevelopmentJan 14, 2015 Sale$19.005,00095,000270,000Jan 16, 2015, 04:31 PM
Hineline Lawrence J.VP of Finance CFODec 09, 2014 Sale$16.5211,535190,55864,700Dec 10, 2014, 05:11 PM
Hineline Lawrence J.VP of Finance CFODec 08, 2014 Sale$16.9110,965185,41876,235Dec 10, 2014, 05:11 PM
Hineline Lawrence J.VP of Finance CFODec 02, 2014 Option Exercise$0.5037,20018,60087,200Dec 03, 2014, 05:43 PM
Alafi Christopher DDirectorDec 01, 2014 Buy$14.751,42220,9753,596,205Dec 03, 2014, 05:42 PM
ALAFI MOSHE10% OwnerDec 01, 2014 Buy$14.751,42220,9753,596,205Dec 03, 2014, 05:40 PM
ALAFI CAPITAL CO LLC10% OwnerDec 01, 2014 Buy$14.751,42220,9753,596,205Dec 03, 2014, 05:39 PM
ALAFI CAPITAL CO LLC10% OwnerNov 28, 2014 Buy$14.7535,000516,2503,594,783Nov 28, 2014, 04:42 PM
ALAFI MOSHE10% OwnerNov 28, 2014 Buy$14.7535,000516,2503,594,783Nov 28, 2014, 04:38 PM
Alafi Christopher DDirectorNov 28, 2014 Buy$14.7535,000516,2503,594,783Nov 28, 2014, 04:36 PM
Mates SharonChairman, President & CEONov 25, 2014 Option Exercise$0.5050,00025,0001,103,935Nov 28, 2014, 04:31 PM
Mates SharonChairman, President & CEONov 28, 2014 Sale$14.7535,000516,2501,068,935Nov 28, 2014, 04:31 PM
Alafi Christopher DDirectorNov 19, 2014 Buy$14.251,03414,7353,559,783Nov 21, 2014, 06:04 PM
ALAFI MOSHE10% OwnerNov 19, 2014 Buy$14.251,03414,7353,559,783Nov 21, 2014, 06:00 PM
ALAFI CAPITAL CO LLC10% OwnerNov 19, 2014 Buy$14.251,03414,7353,559,783Nov 21, 2014, 05:58 PM
Alafi Christopher DDirectorNov 18, 2014 Buy$14.233,53150,2463,558,749Nov 18, 2014, 05:46 PM
Alafi Christopher DDirectorNov 14, 2014 Buy$15.071332,0043,555,218Nov 18, 2014, 05:46 PM
ALAFI MOSHE10% OwnerNov 18, 2014 Buy$14.233,53150,2463,558,749Nov 18, 2014, 05:45 PM
ALAFI MOSHE10% OwnerNov 14, 2014 Buy$15.071332,0043,555,218Nov 18, 2014, 05:45 PM
ALAFI CAPITAL CO LLC10% OwnerNov 18, 2014 Buy$14.233,53150,2463,558,749Nov 18, 2014, 05:43 PM
ALAFI CAPITAL CO LLC10% OwnerNov 14, 2014 Buy$15.071332,0043,555,218Nov 18, 2014, 05:43 PM
Alafi Christopher DDirectorNov 13, 2014 Buy$15.122,20033,2643,555,085Nov 13, 2014, 05:04 PM
Alafi Christopher DDirectorNov 12, 2014 Buy$15.235,00076,1503,552,885Nov 13, 2014, 05:04 PM
Alafi Christopher DDirectorNov 11, 2014 Buy$15.555,00077,7503,547,885Nov 13, 2014, 05:04 PM
ALAFI MOSHE10% OwnerNov 11, 2014 Buy$15.555,00077,7503,547,885Nov 13, 2014, 05:01 PM
ALAFI MOSHE10% OwnerNov 13, 2014 Buy$15.122,20033,2643,555,085Nov 13, 2014, 05:01 PM
ALAFI MOSHE10% OwnerNov 12, 2014 Buy$15.235,00076,1503,552,885Nov 13, 2014, 05:01 PM
ALAFI CAPITAL CO LLC10% OwnerNov 13, 2014 Buy$15.122,20033,2643,555,085Nov 13, 2014, 04:59 PM
ALAFI CAPITAL CO LLC10% OwnerNov 12, 2014 Buy$15.235,00076,1503,552,885Nov 13, 2014, 04:59 PM
ALAFI CAPITAL CO LLC10% OwnerNov 11, 2014 Buy$15.555,00077,7503,547,885Nov 13, 2014, 04:59 PM
Halstead MichaelSVP and General CounselNov 06, 2014 Buy$15.4713,000201,11020,000Nov 06, 2014, 04:53 PM
Halstead MichaelSVP and General CounselNov 05, 2014 Buy$15.217,000106,4707,000Nov 06, 2014, 04:53 PM
Wennogle Lawrence P.Vice President, Drug DiscoveryOct 16, 2014 Sale$15.005,15277,280104,000Oct 17, 2014, 05:00 PM
Wennogle Lawrence P.Vice President, Drug DiscoveryOct 13, 2014 Sale$15.001,60024,000111,156Oct 15, 2014, 04:52 PM
Wennogle Lawrence P.Vice President, Drug DiscoveryOct 15, 2014 Sale$15.002,00430,060109,152Oct 15, 2014, 04:52 PM
Wennogle Lawrence P.Vice President, Drug DiscoveryOct 08, 2014 Sale$15.004,74571,175112,756Oct 10, 2014, 05:05 PM
Wennogle Lawrence P.Vice President, Drug DiscoveryOct 06, 2014 Sale$15.006369,540117,501Oct 07, 2014, 04:30 PM
Wennogle Lawrence P.Vice President, Drug DiscoveryOct 03, 2014 Sale$15.0015,863237,945118,137Oct 07, 2014, 04:30 PM
Wennogle Lawrence P.Vice President, Drug DiscoverySep 15, 2014 Sale$15.005,00075,000134,000Sep 17, 2014, 05:12 PM
Hineline Lawrence J.VP of Finance CFOSep 08, 2014 Option Exercise$0.5030015050,300Sep 10, 2014, 05:33 PM
Hineline Lawrence J.VP of Finance CFOSep 08, 2014 Sale$15.003004,50050,000Sep 10, 2014, 05:33 PM
Wennogle Lawrence P.Vice President, Drug DiscoveryJul 21, 2014 Option Exercise$0.5037,50018,750139,000Jul 22, 2014, 05:31 PM
ALAFI MOSHE10% OwnerJun 19, 2014 Sale$6.3515,742100,0060Jul 10, 2014, 04:56 PM
Fienberg Allen A.VP of Business DevelopmentMay 28, 2014 Option Exercise$0.5037,50018,750275,000Jun 06, 2014, 05:23 PM
Wennogle Lawrence P.Vice President, Drug DiscoveryMay 27, 2014 Sale$15.005,00075,000101,500May 29, 2014, 06:30 PM
Wennogle Lawrence P.Vice President, Drug DiscoveryMay 22, 2014 Sale$15.006,00089,983110,806May 23, 2014, 07:46 PM
RIGGS RORY BDirectorFeb 05, 2014 Buy$17.5028,571499,993240,955Feb 05, 2014, 04:56 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
RIGGS RORY BDirector03/20/2024371,200
Mates SharonChairman, President & CEO03/07/20242,707,277
Mates SharonChairman, President & CEO03/11/20241,341,123
Hineline Lawrence J.SVP of Finance, CFO03/10/2024257,497
Hineline Lawrence J.SVP of Finance, CFO03/11/2024667,587
Hineline Lawrence J.SVP of Finance, CFO03/07/2024874,560
Halstead MichaelEVP and General Counsel03/11/2024484,537
Halstead MichaelEVP and General Counsel03/07/2024868,698
Neumann MarkEVP, Chief Commercial Officer03/11/2024481,931
Neumann MarkEVP, Chief Commercial Officer03/07/2024874,179
Durgam Suresh K.EVP, Chief Medical Officer03/11/2024243,482
Durgam Suresh K.EVP, Chief Medical Officer03/07/2024429,308
VAN NOSTRAND ROBERT LDirector02/27/2024371,200
VAN NOSTRAND ROBERT LDirector02/27/20241,458,650
Halstead MichaelEVP and General Counsel02/26/2024549,784
Hineline Lawrence J.SVP of Finance, CFO02/26/2024216,987
Hineline Lawrence J.SVP of Finance, CFO02/26/2024925,961
Mates SharonChairman, President & CEO02/26/20241,576,464
Durgam Suresh K.EVP, Chief Medical Officer02/26/2024288,534
Neumann MarkEVP, Chief Commercial Officer02/26/2024554,491
MARCUS JOEL SDirector02/26/20241,798,678
MARCUS JOEL SDirector02/26/20241,808,253
Halstead MichaelEVP and General Counsel02/02/2024787,719
Mates SharonChairman, President & CEO02/02/20242,272,693
Neumann MarkEVP, Chief Commercial Officer02/02/2024796,367
Hineline Lawrence J.SVP of Finance, CFO02/02/2024745,037
Durgam Suresh K.EVP, Chief Medical Officer02/02/2024414,355
Mates SharonChairman, President & CEO01/16/20241,270,587
Mates SharonChairman, President & CEO01/18/20241,145,081
Mates SharonChairman, President & CEO01/17/2024810,696
Mates SharonChairman, President & CEO01/16/20245,067,982
Mates SharonChairman, President & CEO01/18/20244,427,849
Mates SharonChairman, President & CEO01/17/20243,185,062
Halstead MichaelEVP and General Counsel01/11/2024680,051
Halstead MichaelEVP and General Counsel01/11/20243,341,698
Durgam Suresh K.EVP, Chief Medical Officer01/02/20241,237,543
Durgam Suresh K.EVP, Chief Medical Officer01/02/20244,397,113
RIGGS RORY BDirector12/31/202317,977
VAN NOSTRAND ROBERT LDirector12/31/20235,443
Durgam Suresh K.EVP, Chief Medical Officer12/13/20231,382,030
Halstead MichaelEVP and General Counsel11/13/2023678,049
Halstead MichaelEVP and General Counsel11/13/20232,694,783
Neumann MarkEVP, Chief Commercial Officer11/06/2023640,491
Neumann MarkEVP, Chief Commercial Officer11/06/20232,358,152
VAN NOSTRAND ROBERT LDirector09/30/20235,469
RIGGS RORY BDirector09/30/202317,971
Mates SharonChairman, President & CEO09/19/20232,405,852
Mates SharonChairman, President & CEO09/18/20232,988,213
Neumann MarkEVP, Chief Commercial Officer08/07/20231,028,027
Neumann MarkEVP, Chief Commercial Officer08/07/20233,251,087
Durgam Suresh K.EVP, Chief Medical Officer07/17/2023119,730
VAN NOSTRAND ROBERT LDirector06/30/20235,382
Hineline Lawrence J.SVP of Finance CFO06/14/20233,462,317
Hineline Lawrence J.SVP of Finance CFO06/14/20235,236,329
VAN NOSTRAND ROBERT LDirector04/17/2023130,500
VAN NOSTRAND ROBERT LDirector04/17/2023630,000
RIGGS RORY BDirector03/31/202316,949
Neumann MarkEVP, Chief Commercial Officer03/28/2023847,380
Durgam Suresh K.EVP, Chief Medical Officer03/13/2023330,794
Neumann MarkEVP, Chief Commercial Officer03/13/2023169,042
Neumann MarkEVP, Chief Commercial Officer03/10/2023370,557
Halstead MichaelEVP and General Counsel03/13/2023330,007
Halstead MichaelEVP and General Counsel03/10/2023720,086
Hineline Lawrence J.SVP of Finance CFO03/13/2023250,808
Hineline Lawrence J.SVP of Finance CFO03/10/2023674,417
Mates SharonChairman, President & CEO03/13/202365,200
Mates SharonChairman, President & CEO03/13/2023925,275
Mates SharonChairman, President & CEO03/10/20231,802,566
Neumann MarkEVP, Chief Commercial Officer03/01/2023362,122
Neumann MarkEVP, Chief Commercial Officer02/24/2023190,648
Durgam Suresh K.SVP, Chief Medical Officer02/24/2023372,689
Halstead MichaelEVP and General Counsel02/24/2023371,819
Hineline Lawrence J.SVP of Finance CFO02/24/2023350,609
Mates SharonChairman, President & CEO02/24/202397,800
Mates SharonChairman, President & CEO02/24/20231,062,408
Neumann MarkEVP, Chief Commercial Officer02/21/2023183,246
Durgam Suresh K.SVP, Chief Medical Officer02/21/2023391,304
Halstead MichaelEVP and General Counsel02/21/2023521,699
Hineline Lawrence J.SVP of Finance CFO02/17/2023687,013
Hineline Lawrence J.SVP of Finance CFO02/21/2023488,891
Hineline Lawrence J.SVP of Finance CFO02/17/20232,689,464
Mates SharonChairman, President & CEO02/21/20231,304,000
VAN NOSTRAND ROBERT LDirector12/30/20225,133
RIGGS RORY BDirector12/30/202216,987
MARCUS JOEL SDirector12/19/2022254,100
Mates SharonChairman, President & CEO12/13/20221,819,565
Halstead MichaelEVP and General Counsel12/01/2022773,500
Halstead MichaelEVP and General Counsel12/01/20222,686,514
MARCUS JOEL SDirector11/07/2022523,023
VAN NOSTRAND ROBERT LDirector09/30/20225,118
RIGGS RORY BDirector09/30/202216,983
Hineline Lawrence J.SVP of Finance CFO09/21/20221,008,087
Hineline Lawrence J.SVP of Finance CFO09/21/20222,973,406
VAN NOSTRAND ROBERT LDirector08/11/2022379,500
VAN NOSTRAND ROBERT LDirector08/11/20221,713,975
MARCUS JOEL SDirector08/11/2022592,200
RIGGS RORY BDirector06/30/202216,496
MARCUS JOEL SDirector05/12/2022550,000
Neumann MarkEVP, Chief Commercial Officer04/08/20221,099,210
Neumann MarkEVP, Chief Commercial Officer04/08/20225,558,051
VAN NOSTRAND ROBERT LDirector03/31/20227,710
RIGGS RORY BDirector03/31/202215,726
RIGGS RORY BDirector03/18/20221,262,505
RIGGS RORY BDirector03/17/20228,536,646
RIGGS RORY BDirector03/16/20223,824,827
Mates SharonChairman, President & CEO03/09/2022110,547
MARCUS JOEL SDirector03/08/2022790,150
MARCUS JOEL SDirector03/07/2022272,600
Durgam Suresh K.Chief Medical Officer03/02/2022238,005
Durgam Suresh K.Chief Medical Officer03/04/2022214,307
Durgam Suresh K.Chief Medical Officer02/24/2022211,468
Neumann MarkEVP, Chief Commercial Officer02/24/2022412,810
Halstead MichaelEVP and General Counsel02/24/2022410,933
Hineline Lawrence J.SVP of Finance CFO02/24/2022387,349
Mates SharonChairman, President & CEO02/24/20221,174,074
Durgam Suresh K.Chief Medical Officer02/22/2022230,958
Neumann MarkEVP, Chief Commercial Officer02/22/2022615,827
Halstead MichaelEVP and General Counsel02/22/2022617,100
Hineline Lawrence J.SVP of Finance CFO02/22/2022578,506
Mates SharonChairman, President & CEO02/22/20221,542,413
Durgam Suresh K.Chief Medical Officer01/18/2022261,553
Durgam Suresh K.Chief Medical Officer01/10/2022280,020
Neumann MarkEVP, Chief Commercial Officer01/10/2022854,255
Halstead MichaelEVP and General Counsel01/10/2022800,774
Hineline Lawrence J.SVP of Finance CFO01/10/2022800,420
Mates SharonChairman, President & CEO01/10/20221,708,429
VAN NOSTRAND ROBERT LDirector12/31/20217,746
RIGGS RORY BDirector12/31/202115,702
Halstead MichaelEVP and General Counsel12/21/20212,897,494
Halstead MichaelEVP and General Counsel12/21/20218,412,278
Hineline Lawrence J.SVP of Finance CFO12/21/20212,941,951
Hineline Lawrence J.SVP of Finance CFO12/21/20218,328,664
Neumann MarkEVP, Chief Commercial Officer10/18/2021549,551
Mates SharonChairman, President & CEO10/15/20213,053
Mates SharonChairman, President & CEO10/15/20211,615,680
Mates SharonChairman, President & CEO10/14/202156,640
Mates SharonChairman, President & CEO10/18/2021327,680
LERNER RICHARD ADirector09/30/202114,987
RIGGS RORY BDirector09/30/202115,732
VAN NOSTRAND ROBERT LDirector09/30/20218,015
Mates SharonChairman, President & CEO08/23/202128,400
VAN NOSTRAND ROBERT LDirector06/30/20217,062
RIGGS RORY BDirector06/30/202115,716
LERNER RICHARD ADirector06/30/202114,981
Alafi Christopher DDirector05/24/20211,075,490
Alafi Christopher DDirector05/21/202144,000
LERNER RICHARD ADirector03/31/202114,997
MARCUS JOEL SDirector03/02/2021531,600
MARCUS JOEL SDirector03/02/2021532,683
Durgam Suresh K.Chief Medical Officer02/19/2021107,310
Neumann MarkEVP, Chief Commercial Officer02/19/2021203,308
Hineline Lawrence J.SVP of Finance CFO02/19/2021409,625
Halstead MichaelEVP and General Counsel02/19/2021437,133
Mates SharonChairman, President & CEO02/19/20211,092,436
Durgam Suresh K.Chief Medical Officer01/11/2021140,259
Neumann MarkEVP, Chief Commercial Officer01/11/2021310,082
Hineline Lawrence J.SVP of Finance CFO01/11/2021628,769
Halstead MichaelEVP and General Counsel01/11/2021628,978
Mates SharonChairman, President & CEO01/11/20211,341,260
Hineline Lawrence J.SVP of Finance CFO01/04/2021495,008
Halstead MichaelEVP and General Counsel01/04/2021505,834
Mates SharonChairman, President & CEO01/04/20211,513,271
LERNER RICHARD ADirector12/31/202014,978
VAN NOSTRAND ROBERT LDirector12/31/20207,060
RIGGS RORY BDirector12/31/202015,741
Alafi Christopher DDirector12/31/202015,741
Mates SharonChairman, President & CEO12/18/202093,160
Halstead MichaelEVP and General Counsel11/17/20201,039,500
Halstead MichaelEVP and General Counsel11/17/20202,193,446
Hineline Lawrence J.SVP of Finance CFO11/11/202061,000
Hineline Lawrence J.SVP of Finance CFO11/11/2020712,344
Mates SharonChairman, President & CEO11/10/20201,317,101
Mates SharonChairman, President & CEO11/04/20201,250,000
Neumann MarkEVP, Chief Commercial Officer10/16/2020182,026
VAN NOSTRAND ROBERT LDirector09/30/20207,082
RIGGS RORY BDirector09/30/202015,730
LERNER RICHARD ADirector09/30/202014,985
Alafi Christopher DDirector09/30/202015,730
Alafi Christopher DDirector09/14/20201,465,200
Hineline Lawrence J.SVP of Finance CFO09/09/2020343,494
Hineline Lawrence J.SVP of Finance CFO09/09/20201,307,351
Alafi Christopher DDirector09/11/2020589,680
VAN NOSTRAND ROBERT LDirector06/30/20207,059
LERNER RICHARD ADirector06/30/202014,991
RIGGS RORY BDirector06/30/202015,736
Alafi Christopher DDirector06/30/202015,736
MARCUS JOEL SDirector05/14/2020192,424
MARCUS JOEL SDirector05/11/2020997,500
MARCUS JOEL SDirector05/13/2020150,537
LERNER RICHARD ADirector05/11/202068,500
LERNER RICHARD ADirector05/11/202071,750
Alafi Christopher DDirector03/31/202015,739
LERNER RICHARD ADirector03/31/202014,986
VAN NOSTRAND ROBERT LDirector03/31/20207,070
RIGGS RORY BDirector03/31/202015,739
Halstead MichaelEVP and General Counsel01/24/202089,930
Hineline Lawrence J.SVP of Finance CFO01/24/202089,930
Mates SharonChairman, President & CEO01/24/2020220,116
LERNER RICHARD ADirector12/31/201913,724
Satlin AndrewEVP and Chief Medical Officer01/09/2020302,750
Neumann MarkEVP, Chief Commercial Officer01/08/2020162,175
Mates SharonChairman, President & CEO01/09/20201,095,973
Halstead MichaelEVP and General Counsel01/09/2020513,730
Hineline Lawrence J.SVP of Finance CFO01/09/2020513,730
Mates SharonChairman, President & CEO01/08/2020164,400
Mates SharonChairman, President & CEO01/06/20201,380,880
Halstead MichaelEVP and General Counsel01/06/2020651,007
Hineline Lawrence J.SVP of Finance CFO01/06/2020650,003
Halstead MichaelEVP and General Counsel01/02/2020253,214
Hineline Lawrence J.SVP of Finance CFO01/02/2020253,165
Mates SharonChairman, President & CEO12/31/201916,440
Mates SharonChairman, President & CEO01/02/2020567,230
VAN NOSTRAND ROBERT LDirector12/31/20195,833
RIGGS RORY BDirector12/31/201914,479
Alafi Christopher DDirector12/31/201914,479
Hineline Lawrence J.SVP of Finance CFO12/23/201926,304
Hineline Lawrence J.SVP of Finance CFO12/23/2019383,316
Neumann MarkEVP, Chief Commercial Officer10/16/201955,886
RIGGS RORY BDirector09/30/201914,499
LERNER RICHARD ADirector09/30/201913,745
VAN NOSTRAND ROBERT LDirector09/30/20195,827
Alafi Christopher DDirector09/30/201914,499
Alafi Christopher DDirector09/10/20194,974,678
Alafi Christopher DDirector08/30/20191,065,212
VAN NOSTRAND ROBERT LDirector06/28/20195,828
LERNER RICHARD ADirector06/28/201913,746
RIGGS RORY BDirector06/28/201914,499
Alafi Christopher DDirector06/28/201914,499
Alafi Christopher DDirector11/22/2017155,500
Alafi Christopher DDirector06/12/20191,993,793
MARCUS JOEL SDirector05/29/2019249,000
Alafi Christopher DDirector05/14/20191,256,350
Alafi Christopher DDirector03/31/201914,494
VAN NOSTRAND ROBERT LDirector03/31/20195,822
RIGGS RORY BDirector03/31/201914,494
LERNER RICHARD ADirector03/31/201913,739
Hineline Lawrence J.SVP of Finance CFO02/27/201928,496
Hineline Lawrence J.SVP of Finance CFO02/27/201915,000
Mates SharonChairman, President & CEO01/07/201982,088
Mates SharonChairman, President & CEO01/04/2019522,222
Halstead MichaelEVP and General Counsel01/07/201938,601
Halstead MichaelEVP and General Counsel01/04/2019245,817
Hineline Lawrence J.SVP of Finance CFO01/07/201938,601
Hineline Lawrence J.SVP of Finance CFO01/04/2019245,782
Vanover Kimberly E.SVP, Early Stage Clinical Dev.01/04/2019109,704
Vanover Kimberly E.SVP, Early Stage Clinical Dev.01/07/20197,276
Davis Robert ESVP, Chief Scientific Officer01/04/2019109,630
Mates SharonChairman, President & CEO01/02/2019193,831
Halstead MichaelEVP and General Counsel01/02/201986,580
Vanover Kimberly E.SVP, Early Stage Clinical Dev.01/02/201953,657
Davis Robert ESVP, Chief Scientific Officer01/02/201953,706
Hineline Lawrence J.SVP of Finance CFO01/02/201986,580
VAN NOSTRAND ROBERT LDirector12/31/20185,832
RIGGS RORY BDirector12/31/201814,499
LERNER RICHARD ADirector12/31/201813,748
Alafi Christopher DDirector12/31/201814,499
Mates SharonChairman, President & CEO12/10/201875,000
Davis Robert ESVP, Chief Scientific Officer12/06/201812,163
MARCUS JOEL SDirector11/12/2018125,580
MARCUS JOEL SDirector11/09/2018456,000
LERNER RICHARD ADirector10/22/201818,750
LERNER RICHARD ADirector09/30/201813,736
RIGGS RORY BDirector09/30/201814,496
VAN NOSTRAND ROBERT LDirector09/30/20185,816
Alafi Christopher DDirector09/30/201814,496
LERNER RICHARD ADirector06/29/201813,747
Alafi Christopher DDirector06/29/201814,489
VAN NOSTRAND ROBERT LDirector06/29/20184,983
RIGGS RORY BDirector06/29/201814,489
VAN NOSTRAND ROBERT LDirector03/30/20184,989
RIGGS RORY BDirector03/30/201814,482
LERNER RICHARD ADirector03/30/201813,746
Alafi Christopher DDirector03/30/201814,482
Hineline Lawrence J.VP of Finance CFO02/16/2018326,543
Hineline Lawrence J.VP of Finance CFO02/15/2018668,621
Halstead MichaelSVP and General Counsel01/22/2018459,765
Vanover Kimberly E.SVP, Clinical Development01/08/201813,479
Mates SharonChairman, President & CEO01/08/2018115,438
Mates SharonChairman, President & CEO01/05/2018192,270
Vanover Kimberly E.SVP, Clinical Development01/05/201820,583
Davis Robert ESVP, Chief Scientific Officer01/04/201817,394
Hineline Lawrence J.VP of Finance CFO01/04/201850,019
Hineline Lawrence J.VP of Finance CFO01/05/201832,706
Halstead MichaelSVP and General Counsel01/05/201827,284
Halstead MichaelSVP and General Counsel01/04/201841,895
VAN NOSTRAND ROBERT LDirector12/29/20174,996
RIGGS RORY BDirector12/29/201714,494
LERNER RICHARD ADirector12/29/201713,742
Alafi Christopher DDirector12/29/201714,494
VAN NOSTRAND ROBERT LDirector12/29/20174,996
LERNER RICHARD ADirector12/29/201713,742
RIGGS RORY BDirector12/29/201714,494
Alafi Christopher DDirector12/29/201714,494
LERNER RICHARD ADirector12/11/201718,750
LERNER RICHARD ADirector12/11/2017105,630
Davis Robert ESVP, Chief Scientific Officer12/05/20179,750
Alafi Christopher DDirector11/22/2017155,500
Mates SharonChairman, President & CEO10/30/201728,125
Mates SharonChairman, President & CEO10/30/2017295,313
ALAFI MOSHE10% Owner10/02/20174,000,008
Alafi Christopher DDirector10/02/20174,000,008
ALAFI CAPITAL CO LLC10% Owner10/02/20174,000,008
MARCUS JOEL SDirector01/26/2017247,450
Vanover Kimberly E.SVP, Clinical Development01/05/201713,272
Mates SharonChairman, President & CEO01/05/201767,541
Hineline Lawrence J.VP of Finance CFO01/05/201731,800
Halstead MichaelSVP and General Counsel01/05/201726,497
Vanover Kimberly E.SVP, Clinical Development12/15/201627,425
Vanover Kimberly E.SVP, Clinical Development12/15/2016142,773
ALAFI MOSHE10% Owner12/07/2016336,038
ALAFI MOSHE10% Owner12/06/2016721,445
Alafi Christopher DDirector12/07/2016336,038
Alafi Christopher DDirector12/06/2016721,445
ALAFI CAPITAL CO LLC10% Owner12/07/2016336,038
ALAFI CAPITAL CO LLC10% Owner12/06/2016721,445
ALAFI MOSHE10% Owner11/14/2016492,969
ALAFI CAPITAL CO LLC10% Owner11/14/2016492,969
Alafi Christopher DDirector11/14/2016492,969
RIGGS RORY BDirector02/05/2014249,988
RIGGS RORY BDirector02/05/2014250,005
Alafi Christopher DDirector02/29/20162,970,300
LERNER RICHARD ADirector02/18/201613,600
VAN NOSTRAND ROBERT LDirector12/31/20153,712
RIGGS RORY BDirector12/31/201510,597
MARCUS JOEL SDirector12/31/201510,704
Alafi Christopher DDirector12/31/201510,489
LERNER RICHARD ADirector12/31/201510,113
Mates SharonChairman, President & CEO12/11/201577,125
Mates SharonChairman, President & CEO12/11/20152,774,441
Hineline Lawrence J.VP of Finance CFO12/15/201550,750
Hineline Lawrence J.VP of Finance CFO12/14/20154,500
Hineline Lawrence J.VP of Finance CFO11/24/20153,000
Hineline Lawrence J.VP of Finance CFO12/15/20151,169,226
Hineline Lawrence J.VP of Finance CFO12/14/20151,146,140
MARCUS JOEL SDirector12/08/20151,243,960
MARCUS JOEL SDirector12/07/20152,126,628
MARCUS JOEL SDirector12/04/20151,678,800
Hineline Lawrence J.VP of Finance CFO11/24/2015275,000
Fienberg Allen A.VP of Business Development09/09/201517,000
Fienberg Allen A.VP of Business Development08/21/20156,060
Fienberg Allen A.VP of Business Development08/19/2015303,000
Wennogle Lawrence P.Vice President, Drug Discovery06/08/2015671,000
Wennogle Lawrence P.Vice President, Drug Discovery05/19/201558,250
Fienberg Allen A.VP of Business Development03/31/20157,500
MARCUS JOEL SDirector03/31/201518,400
Alafi Christopher DDirector03/11/201515,000,000
Fienberg Allen A.VP of Business Development01/14/201595,000
Hineline Lawrence J.VP of Finance CFO12/09/2014190,558
Hineline Lawrence J.VP of Finance CFO12/08/2014185,418
Hineline Lawrence J.VP of Finance CFO12/02/201418,600
Alafi Christopher DDirector12/01/201420,975
ALAFI MOSHE10% Owner12/01/201420,975
ALAFI CAPITAL CO LLC10% Owner12/01/201420,975
ALAFI CAPITAL CO LLC10% Owner11/28/2014516,250
ALAFI MOSHE10% Owner11/28/2014516,250
Alafi Christopher DDirector11/28/2014516,250
Mates SharonChairman, President & CEO11/25/201425,000
Mates SharonChairman, President & CEO11/28/2014516,250
Alafi Christopher DDirector11/19/201414,735
ALAFI MOSHE10% Owner11/19/201414,735
ALAFI CAPITAL CO LLC10% Owner11/19/201414,735
Alafi Christopher DDirector11/18/201450,246
Alafi Christopher DDirector11/14/20142,004
ALAFI MOSHE10% Owner11/18/201450,246
ALAFI MOSHE10% Owner11/14/20142,004
ALAFI CAPITAL CO LLC10% Owner11/18/201450,246
ALAFI CAPITAL CO LLC10% Owner11/14/20142,004
Alafi Christopher DDirector11/13/201433,264
Alafi Christopher DDirector11/12/201476,150
Alafi Christopher DDirector11/11/201477,750
ALAFI MOSHE10% Owner11/11/201477,750
ALAFI MOSHE10% Owner11/13/201433,264
ALAFI MOSHE10% Owner11/12/201476,150
ALAFI CAPITAL CO LLC10% Owner11/13/201433,264
ALAFI CAPITAL CO LLC10% Owner11/12/201476,150
ALAFI CAPITAL CO LLC10% Owner11/11/201477,750
Halstead MichaelSVP and General Counsel11/06/2014201,110
Halstead MichaelSVP and General Counsel11/05/2014106,470
Wennogle Lawrence P.Vice President, Drug Discovery10/16/201477,280
Wennogle Lawrence P.Vice President, Drug Discovery10/13/201424,000
Wennogle Lawrence P.Vice President, Drug Discovery10/15/201430,060
Wennogle Lawrence P.Vice President, Drug Discovery10/08/201471,175
Wennogle Lawrence P.Vice President, Drug Discovery10/06/20149,540
Wennogle Lawrence P.Vice President, Drug Discovery10/03/2014237,945
Wennogle Lawrence P.Vice President, Drug Discovery09/15/201475,000
Hineline Lawrence J.VP of Finance CFO09/08/2014150
Hineline Lawrence J.VP of Finance CFO09/08/20144,500
Wennogle Lawrence P.Vice President, Drug Discovery07/21/201418,750
ALAFI MOSHE10% Owner06/19/2014100,006
Fienberg Allen A.VP of Business Development05/28/201418,750
Wennogle Lawrence P.Vice President, Drug Discovery05/27/201475,000
Wennogle Lawrence P.Vice President, Drug Discovery05/22/201489,983
RIGGS RORY BDirector02/05/2014499,993
Load More Insider Transactions
FUNDS WITH A POSITION IN INTRA-CELLULAR THERAPIES INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.8,193,5440.01%9.03%Other
GEODE CAPITAL MANAGEMENT, LLC2,001,7910.02%4.75%Other
HOLOCENE ADVISORS, LP1,261,8570.35%-11.91%Growth At A Reasonable Price
SUVRETTA CAPITAL MANAGEMENT, LLC1,165,9483.78%-14.88%Growth At A Reasonable Price
ADAGE CAPITAL PARTNERS GP, L.L.C.275,0000.04%-68.93%Other
D. E. SHAW & CO., INC.511,5500.03%-31%Other
BALYASNY ASSET MANAGEMENT L.P.309,9930.04%NewEvent Driven
RENAISSANCE TECHNOLOGIES LLC152,4000.02%-42.27%Other
TIG ADVISORS, LLC129,300 (Call)1.16%NewEvent Driven
TUDOR INVESTMENT CORP ET AL51,5550.03%42.11%Event Driven, Other
BALYASNY ASSET MANAGEMENT L.P.50,000 (Call)0.00672%NewEvent Driven
AQR CAPITAL MANAGEMENT LLC38,7130.00522%29.31%Other
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)2,9100.00385%NewOther
CHANGE IN SHARES OUTSTANDING FOR INTRA-CELLULAR THERAPIES INC
STOCK BUYBACKS FOR INTRA-CELLULAR THERAPIES INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.15%
1Q
12/31/2023
06/30/2023
0.36%
2Q
12/31/2023
03/31/2023
1.21%
3Q
12/31/2023
12/31/2022
1.62%
4Q
12/31/2023
09/30/2022
1.88%
5Q
12/31/2023
06/30/2022
2.13%
6Q
12/31/2023
03/31/2022
3.98%
7Q
12/31/2023
12/31/2021
18.18%
8Q
12/31/2023
09/30/2021
18.36%
9Q
12/31/2023
06/30/2021
18.54%
10Q
12/31/2023
03/31/2021
18.96%
11Q
12/31/2023
12/31/2020
19.81%
12Q
12/31/2023
09/30/2020
38.49%
13Q
12/31/2023
06/30/2020
44.95%
14Q
12/31/2023
03/31/2020
47.90%
15Q
12/31/2023
12/31/2019
74.19%
16Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.15%
1Q
06/30/2023
0.36%
2Q
03/31/2023
1.21%
3Q
12/31/2022
1.62%
4Q
09/30/2022
1.88%
5Q
06/30/2022
2.13%
6Q
03/31/2022
3.98%
7Q
12/31/2021
18.18%
8Q
09/30/2021
18.36%
9Q
06/30/2021
18.54%
10Q
03/31/2021
18.96%
11Q
12/31/2020
19.81%
12Q
09/30/2020
38.49%
13Q
06/30/2020
44.95%
14Q
03/31/2020
47.90%
15Q
12/31/2019
74.19%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR INTRA-CELLULAR THERAPIES INC
LOADING...